Close
4

Evonik Evonik

X

Company profile for Allyx Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Allyx Therapeutics is focused on introducing a novel approach to preserve and protect synapses for individuals with neurodegenerative diseases. Their lead compound, ALX-001, represents a first-in-class oral therapy with a distinctive mechanism of action targeting mGluR5. Clinical programs, particularly in Alzheimer's disease (Phase 1b), are actively progressing. Founded in 2019 by a team of Yale scientists, experienced biophar...
Allyx Therapeutics is focused on introducing a novel approach to preserve and protect synapses for individuals with neurodegenerative diseases. Their lead compound, ALX-001, represents a first-in-class oral therapy with a distinctive mechanism of action targeting mGluR5. Clinical programs, particularly in Alzheimer's disease (Phase 1b), are actively progressing. Founded in 2019 by a team of Yale scientists, experienced biopharma industry professionals, and venture capitalists, Allyx has secured funding from various sources, including non-dilutive support from the National Institutes of Health (NIH).

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Allyx Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
555 Long Wharf Drive Floor 11 New Haven, CT 06511
Telephone
Telephone

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY